The image of pharma as corrupt is not a problem of perception. It’s one of fact.
Watching pharma executives, sometimes you have to wonder, “Will these guys ever learn?” Case in point, industry’s assault on the FDA’s conflict-of-interest rules.
Get the most out of
Register for free and enjoy unlimited access to: